Conrad Siegel Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
GIM
PCA
Conrad Siegel Investment Advisors's LLY Position: Q3 2026 in Review
Conrad Siegel Investment Advisors increased its Eli Lilly (LLY) stake by 2.3% in Q3 2026, buying an estimated $9.44K and bringing the position to 358 shares worth $414K. The position accounts for 0.07% of the portfolio, ranked #53.
Conrad Siegel Investment Advisors first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $420K in Q2 2026. 814 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Conrad Siegel Investment Advisors held 358 shares of Eli Lilly worth $414K as of Q3 2026.
- Conrad Siegel Investment Advisors bought 8 Eli Lilly shares in Q3 2026, an estimated $9.44K.
- Eli Lilly made up 0.07% of Conrad Siegel Investment Advisors's portfolio in Q3 2026, its #53 holding.
- Conrad Siegel Investment Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
- Conrad Siegel Investment Advisors's Eli Lilly position peaked at $420K in Q2 2026.
- 814 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Conrad Siegel Investment Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.